Inspired by nature. Refined by science.

Next Generation Psychedelics for the Mind and Cannabinoids for the Body

 

Our Mission

Extending and Enhancing Quality of Life for Patients and Their Families

 

Real Science

Deep Expertise in Synthetic Chemistry and Biology

PsyAI™

A Powerful, Bespoke AI Engine to Identify the Best Molecules

 

About Enveric

Enveric Biosciences is leveraging its discovery engine and intellectual property portfolio to identify and build the next generation of psychedelic and cannabinoid medicines for the mind and body. By harnessing the power of synthetic biology and chemistry, the company is optimizing what nature created to improve the human condition.

14
Patents Filed
2
Clinic-Ready Programs in Cancer
6
Industry-Leading Collaborations

Psychedelic Therapies

Enveric is focused on synthesizing novel, tailored and highly commercial derivative molecules based on classic psychedelics.

CBD Combinations

Enveric seeks to advance novel combinations of CBD with chemotherapeutic agents and immunotherapies.

Development Programs

Enveric has a robust pipeline with multiple data points expected in 2022 for radiodermatitis and glioblastoma.